ATE394373T1 - Synthese von indolthiazolverbindungen als liganden des ah-rezeptors - Google Patents

Synthese von indolthiazolverbindungen als liganden des ah-rezeptors

Info

Publication number
ATE394373T1
ATE394373T1 AT03707863T AT03707863T ATE394373T1 AT E394373 T1 ATE394373 T1 AT E394373T1 AT 03707863 T AT03707863 T AT 03707863T AT 03707863 T AT03707863 T AT 03707863T AT E394373 T1 ATE394373 T1 AT E394373T1
Authority
AT
Austria
Prior art keywords
synthesis
indolthiazole
ligands
receptor
compounds
Prior art date
Application number
AT03707863T
Other languages
English (en)
Inventor
Hector Deluca
Pawel Grzywacz
Rafal Sicinski
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/074,102 external-priority patent/US6916834B2/en
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Application granted granted Critical
Publication of ATE394373T1 publication Critical patent/ATE394373T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT03707863T 2002-02-12 2003-02-11 Synthese von indolthiazolverbindungen als liganden des ah-rezeptors ATE394373T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35658502P 2002-02-12 2002-02-12
US10/074,102 US6916834B2 (en) 2001-02-14 2002-02-12 Preparations and use of an Ah receptor ligand, 2-(1′H-indole-3′-carbonyl)-thiazole-4-carboxylic acid methyl ester

Publications (1)

Publication Number Publication Date
ATE394373T1 true ATE394373T1 (de) 2008-05-15

Family

ID=27736819

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03707863T ATE394373T1 (de) 2002-02-12 2003-02-11 Synthese von indolthiazolverbindungen als liganden des ah-rezeptors

Country Status (10)

Country Link
US (2) US7002019B2 (de)
EP (1) EP1480951B1 (de)
JP (1) JP4445266B2 (de)
CN (2) CN1915991B (de)
AT (1) ATE394373T1 (de)
AU (1) AU2003209130B2 (de)
CA (1) CA2475331C (de)
DE (1) DE60320766D1 (de)
MX (1) MXPA04007767A (de)
WO (1) WO2003068742A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL157301A0 (en) * 2001-02-14 2004-02-19 Wisconsin Alumni Res Found Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester
DE60221391T2 (de) 2001-06-20 2008-04-17 Wyeth Substituierte indolsäurederivate als inhibitoren von plasminogen-aktivator-inhibitor-1 (pai-1)
TWI224101B (en) 2001-06-20 2004-11-21 Wyeth Corp Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
CN1915991B (zh) * 2002-02-12 2010-05-26 威斯康星校友研究基金会 用于ah受体作为配体的吲哚噻唑化合物的合成
US7056943B2 (en) 2002-12-10 2006-06-06 Wyeth Substituted indole oxo-acetyl amino acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
BR0316574A (pt) 2002-12-10 2005-10-04 Wyeth Corp Derivados de ácido acético 3-carbonil-1h-indol-1-il substituìdo como inibidores do inibidor-1 do ativador do plasminogênio (pai-1)
UA80453C2 (en) 2002-12-10 2007-09-25 Derivatives of substituted dyhydropyranoindol-3,4-dion as inhibitors of plasminogen activator inhibitor-1 (pai-1)
DK1569899T3 (da) 2002-12-10 2006-10-23 Wyeth Corp Substituerede 3-alkyl- og 3-arylalkyl-1H-indol-1-yl-eddikesyrederivater som inhibitorer af plasminogenaktivator-inhibitor-1 (PAI-1)
CA2509191A1 (en) 2002-12-10 2004-06-24 Wyeth Aryl, aryloxy, and alkyloxy substituted 1h-indol-3-yl glyoxylic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)
US7230133B2 (en) 2003-05-01 2007-06-12 Bristol-Myers Squibb Company Malonamides and malonamide derivatives as modulators of chemokine receptor activity
US7442805B2 (en) 2003-09-25 2008-10-28 Wyeth Substituted sulfonamide-indoles
US7446201B2 (en) 2003-09-25 2008-11-04 Wyeth Substituted heteroaryl benzofuran acids
US7411083B2 (en) 2003-09-25 2008-08-12 Wyeth Substituted acetic acid derivatives
US7582773B2 (en) 2003-09-25 2009-09-01 Wyeth Substituted phenyl indoles
US7141592B2 (en) 2003-09-25 2006-11-28 Wyeth Substituted oxadiazolidinediones
US7265148B2 (en) 2003-09-25 2007-09-04 Wyeth Substituted pyrrole-indoles
US7351726B2 (en) 2003-09-25 2008-04-01 Wyeth Substituted oxadiazolidinediones
US7268159B2 (en) 2003-09-25 2007-09-11 Wyeth Substituted indoles
US7163954B2 (en) 2003-09-25 2007-01-16 Wyeth Substituted naphthyl benzothiophene acids
US7420083B2 (en) 2003-09-25 2008-09-02 Wyeth Substituted aryloximes
US7332521B2 (en) 2003-09-25 2008-02-19 Wyeth Substituted indoles
US7342039B2 (en) 2003-09-25 2008-03-11 Wyeth Substituted indole oximes
US7534894B2 (en) 2003-09-25 2009-05-19 Wyeth Biphenyloxy-acids
CA2577846A1 (en) 2004-08-23 2006-03-02 Wyeth Thiazolo-naphthyl acids as inhibitors of plasminogen activator inhibitor-1
US7754747B2 (en) 2004-08-23 2010-07-13 Wyeth Llc Oxazolo-naphthyl acids
JP2008510814A (ja) 2004-08-23 2008-04-10 ワイス Pai−1阻害剤としてのピロロ−ナフチル酸
EP1919866A2 (de) 2005-08-17 2008-05-14 Wyeth a Corporation of the State of Delaware Substituierte indole und deren verwendung
EP2082736A1 (de) * 2008-01-23 2009-07-29 Jean Hilaire Saurat Pharmazeutische Zusammensetzung zur lokalen Anwendung
US8236849B2 (en) 2008-10-15 2012-08-07 Ohio Northern University Model for glutamate racemase inhibitors and glutamate racemase antibacterial agents
AU2010313622B2 (en) 2009-11-02 2014-08-14 Ahr Pharmaceuticals, Inc. ITE for cancer intervention and eradication
US10632106B2 (en) 2009-11-02 2020-04-28 Ariagen, Inc. Methods of cancer treatment with 2-(1′H-Indole-3′-carbonyl)-thiazole-4-carboxylic acid methyl ester
CN102775399A (zh) * 2011-12-27 2012-11-14 盛世泰科生物医药技术(苏州)有限公司 arylhydrocarbon受体(AHR)的内源性配体,2-(1’H3’-吲哚羰基)噻唑-4-羧酸甲酯的合成新方法
US10711106B2 (en) * 2013-07-25 2020-07-14 The University Of Chicago High aspect ratio nanofibril materials
EP3191481B1 (de) 2014-09-12 2020-11-25 Ariagen, Inc. Effiziente und skalierbare synthese von 2-(1'h-indol-3'-carbonyl)-thiazol-4-carboxylsäuremethylester und strukturelle analoga davon
CN113480530A (zh) 2016-12-26 2021-10-08 阿里根公司 芳香烃受体调节剂
KR20200089718A (ko) 2017-11-20 2020-07-27 아리아젠, 인크. 인돌 화합물 및 이의 용도
CA3137027A1 (en) 2019-04-15 2020-10-22 Ariagen, Inc. Chiral indole compounds and their use
US11136318B2 (en) 2019-06-21 2021-10-05 Noramco, Llc Processes for the preparation of aryl hydrocarbon receptor ligands

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3265931A (en) * 1964-09-21 1966-08-09 Martin E Gerry Magnetic ignition distributor
US3285931A (en) 1964-12-21 1966-11-15 Union Carbide Corp Preparation of substituted pyrrole derivatives
US5366685A (en) 1989-07-18 1994-11-22 Idemitsu Petrochemical Co., Ltd. Process of molding thermoplastic sheet by plug assist vacuum forming
US6323228B1 (en) * 2000-09-15 2001-11-27 Abbott Laboratories 3-substituted indole angiogenesis inhibitors
US6523228B1 (en) * 2000-10-26 2003-02-25 Avery Dennison Corporation Tamper-proof tie
IL157301A0 (en) * 2001-02-14 2004-02-19 Wisconsin Alumni Res Found Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester
EP1427413A2 (de) * 2001-09-13 2004-06-16 Synta Pharmaceuticals Corporation 2-aroylimidazol-verbindungen zur behandlung von krebs
CN1915991B (zh) * 2002-02-12 2010-05-26 威斯康星校友研究基金会 用于ah受体作为配体的吲哚噻唑化合物的合成

Also Published As

Publication number Publication date
CN1915991B (zh) 2010-05-26
JP4445266B2 (ja) 2010-04-07
WO2003068742A1 (en) 2003-08-21
EP1480951A1 (de) 2004-12-01
US7241900B2 (en) 2007-07-10
AU2003209130B2 (en) 2008-06-05
JP2005525340A (ja) 2005-08-25
US20060079692A1 (en) 2006-04-13
CN1642910A (zh) 2005-07-20
CN1915991A (zh) 2007-02-21
US7002019B2 (en) 2006-02-21
MXPA04007767A (es) 2004-10-15
EP1480951A4 (de) 2006-03-22
CA2475331C (en) 2012-06-12
AU2003209130A1 (en) 2003-09-04
EP1480951B1 (de) 2008-05-07
CA2475331A1 (en) 2003-08-21
DE60320766D1 (de) 2008-06-19
US20040204588A1 (en) 2004-10-14

Similar Documents

Publication Publication Date Title
DE60320766D1 (de) Synthese von indolthiazolverbindungen als liganden des ah-rezeptors
ATE423113T1 (de) Substituierte oxoazaheterozyclische verbindungen
NO20093402L (no) Framgangsmate for syntetisering av camptothesin relaterte forbindelser
NO20063380L (no) Triazolderivater som vasopressinantagonister
ATE452882T1 (de) Herstellung von quetiapin
ATE357434T1 (de) Disubstituierte thiazolylcarboxanilide und ihre verwendung als mikrobizide
NO982850L (no) Ny syntese
NO20060219L (no) Forbindelser
GB0031103D0 (en) Chemical compounds
TR200100698T2 (tr) 5-HT4 alıcı-Antagonistleri olarak Dihidrobenzodioksin Karboksamit ve Keton türevleri
ATE301117T1 (de) Neue cyclopropane als cgrp-antagonisten, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
EA200401470A1 (ru) Производные пиперазинилацилпиперидина, их получение и их терапевтическое применение
ATE429429T1 (de) Pharmazeutisches verfahren und damit hergestellte verbindungen
TR200302288T2 (tr) Terapi için yeni bileşikler ve metotlar.
NO20053312L (no) Benzofuranderivat.
BR0209901A (pt) Processos para a sìntese de derivados de 2,3-dihidro-1,4-dioxino-[2,3-f] quinolina
DE60235365D1 (de) Verfahren zur herstellung von 7-amino-syn-3,5-dihydroxyheptansäurederivaten und zwischenverbindungen diesesverfahrens und deren herestellung
WO2005000804A3 (en) Substituted indoles and a process for preparing substituted indoles
IS7181A (is) Aralkýl-tetrahýdró-pýridín, framleiðsla þeirra oglyfjasamsetningar sem innihalda þau
ATE257831T1 (de) Synthese von wasserlöslischem 9-dihydroplacitaxel derivate aus 9-dihydro-13-acetylbacchatin iii
WO2004039776A3 (en) A process for the preparation of benzyl 2-oxo-4- (heteroaryl) dithio-alpha-isoprenyl-1- azetidineazetate derivatives
CA2203850A1 (en) Novel n-phenyl-n-phenyliminonethylbenzamidines and their analogues as muscarinic receptor agonists
DK1105392T3 (da) Fremgangsmåde til fremstilling af mellemprodukter for imidazodiazepin
MY139258A (en) Carbamoyl-type benzofuran derivatives
ES2151442B1 (es) Nuevo derivado del bencenoetanol.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties